Exploration of Fenestration Decompression Combined With Dalafenib in the Treatment of BRAF Mutant Ameloblastoma
Clinical trial NCT06264778 · UNKNOWN
Trial details
- NCT number
- NCT06264778
- Sponsor
- Shandong University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-01
- Primary completion
- 2025-11-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.